White Paper

CRISPR, Gene-Based Therapeutics, And Clinical Trials

Source: Worldwide Clinical Trials
Gene therapy data GettyImages-1054555460

At the border between discovery and clinical development lies a space that is simultaneously unknown yet seemingly full of potential. One such space is that created by the discovery of CRISPR-CAS9 gene editing technique. Never before have researchers had so precise a tool with which to make controlled changes to genetic material—in plants, animals, and humans. This discovery has fueled the imaginations of researchers and innovators around the globe and it has expanded significantly the potential for highly targeted advanced therapy medicinal products (ATMPS) in multiple therapeutic areas.

This series on CRISPR technology explores domains relevant to professional staff accountable for the design in the implementation of strategic clinical development programs involving advanced therapy medicinal products (ATMPS), beginning with translational medicine to the interface of discovery with development.


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader